한글목차

세계 애완동물용 백신 시장의 미래는 개, 고양이, 토끼 용도에서의 기회로 인해 유망할 것으로 보입니다. 세계 애완동물용 백신 시장은 2025-2031년 6.1%의 연평균 복합 성장률(CAGR)로 2031년까지 약 112억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 반려동물 사육 수 증가, 반려동물 예방접종의 이점에 대한 보호자의 인식 증가, 예방접종에 대한 정부 규제 등이 있습니다.

• Lucintel은 반려동물의 인기 증가, 동물 건강의 중요성에 대한 인식 증가, 반려동물 소유자의 라이프스타일 변화로 인해 개과 동물이 백신 접종 카테고리에서 가장 큰 부문을 차지할 것으로 예측했습니다.
• 용도별로는 개가 예측 기간 중 가장 높은 성장을 보일 것으로 예상됩니다.
• 지역별로는 반려동물을 심각한 질병으로부터 보호하기 위한 백신 접종에 대한 정부의 엄격한 규제와 미국내 반려동물 사육 증가로 인해 북미가 가장 규모가 큰 지역으로 남을 것으로 보입니다.

애완동물용 백신 시장의 전략적 성장 기회

애완동물용 백신 시장은 효과적인 백신에 대한 수요 증가와 반려동물의 예방의학에 대한 관심 증가로 인해 다양한 용도를 통해 몇 가지 전략적 성장 기회를 제공합니다. 여기서는 용도별로 5가지 주요 성장 기회를 소개합니다.

• 정기 예방접종 프로그램 확대: 정기 예방접종 프로그램 대상 백신의 범위를 확대하는 것은 큰 성장을 가속할 수 있습니다. 이러한 접근 방식은 여러 질병에 대한 종합적인 보호를 보장하고 수의사에게 더 자주 방문하도록 유도하여 전체 애완동물용 백신 시장의 성장을 가속할 수 있습니다.
• 이국적인 반려동물에 특화된 백신 개발: 파충류, 조류 등 이국적인 반려동물에 특화된 백신 개발의 가능성은 전략적 성장 기회가 될 수 있습니다. 시장 확대의 원동력은 이국적인 반려동물의 사육이 증가하는 한편, 그들의 고유한 건강 요구사항에 대한 백신에 대한 수요가 증가하는 것입니다.
• 반려동물 웰니스 프로그램과의 통합: 종합적인 반려동물 웰니스 프로그램에 백신을 통합하면 예방의학 활성화를 통한 전략적 성장 기회를 얻을 수 있습니다. 이러한 프로그램에는 정기 검진 및 백신 접종이 포함되어 반려동물의 일관된 관리를 보장하고 질병 발생을 줄일 수 있습니다.
• 이동 수의학 서비스 이용 가능성 증가: 특히 농촌 지역이나 서비스가 부족한 지역사회에서 이동 수의학 서비스를 이용할 수 있게 되면 백신에 대한 접근성이 향상되어 성장 기회가 생길 수 있습니다. 이러한 서비스는 기존 동물병원을 찾기 어려운 반려동물 보호자에게도 제공되어 백신 접종 수준을 향상시킬 수 있습니다.
• 반려동물 예방접종 및 여행용 예방접종 성장: 반려동물과 함께 여행하는 반려동물 보호자가 증가함에 따라 여행 관련 예방접종에 대한 수요가 증가하고 있습니다. 이에 따라 여행용 반려동물 전용 백신을 개발 및 판매하는 것은 이러한 사람들의 니즈를 충족시킬 수 있는 전략적 성장 기회가 될 수 있습니다.

애완동물용 백신 시장은 백신 접종률을 높이고, 접근성을 개선하고, 보호자의 다양한 요구에 부응하기 위한 집중적인 투자로 인해 크게 성장할 것으로 예상됩니다.

애완동물용 백신 시장 활성화 요인 및 과제

수많은 기술적, 경제적, 규제적 요인들이 애완동물용 백신 시장의 성장에 영향을 미치고 과제를 제시하고 있습니다. 백신의 효능은 기술 발전에 의해 개선되고, 경제적인 요인에 의해 가격이 결정되며, 시장 역학은 규제적 장애물에 의해 형성됩니다. 따라서 이러한 시장 성장 촉진요인과 과제를 이해하는 것은 시장을 잘 이해하고 성장과 혁신을 위한 영역을 파악하는 데 매우 중요합니다.

애완동물용 백신 시장을 촉진하는 요인은 다음과 같습니다. :

• 반려동물 양육 인구 증가: 전 세계 반려동물 양육 인구 증가로 애완동물용 백신에 대한 수요가 증가하고 있습니다. 반려동물을 키우는 가정이 늘어남에 따라 일반적인 질병을 예방하는 백신의 필요성이 증가하고 있습니다. 이러한 추세는 시장 확장을 지원하고 다양한 건강 요구를 충족시키는 새로운 백신 제품 개발을 촉진하고 있습니다.
• 백신 기술의 발전: 보다 효과적이고 안전한 제제를 포함한 백신 기술의 혁신은 시장 성장의 중요한 촉진제이며, mRNA 백신 및 전달 시스템 개선과 같은 첨단 기술은 백신의 효능과 안전성을 높이고, 시장 잠재력을 확대하며, 반려동물의 새로운 건강 위협에 대처할 수 있도록 합니다.
• 반려동물 건강에 대한 인식 증가: 예방접종의 중요성에 대한 보호자들의 인식이 높아지면서 시장 수요를 견인하고 있습니다. 반려동물 보호자들이 백신의 이점에 대한 지식이 높아짐에 따라 백신 접종 일정을 준수하는 경향이 높아져 시장 보급률이 증가하고 반려동물의 전반적인 건강 상태가 개선될 것으로 예상됩니다.
• 정부 및 규제 당국의 지원: 백신 접종 캠페인, 보조금 지원 등 정부 및 규제기관의 지원은 시장 성장을 가속합니다. 이러한 노력은 백신의 안전성과 유효성을 보장하고 합리적인 가격으로 백신을 이용할 수 있도록 하여 반려동물의 백신 접종 수준을 향상시킵니다.
• 수의학 서비스 확대: 새로운 진료소 및 이동 진료소를 포함한 수의학 서비스 확대는 애완동물용 백신에 대한 접근성을 향상시킬 수 있습니다. 접근성 향상은 백신 접종률 향상으로 이어지며, 서비스 취약 지역으로 시장 확대와 종합적인 반려동물 의료 서비스 제공으로 이어질 수 있습니다.

애완동물용 백신 시장이 해결해야 할 과제는 다음과 같습니다. :

• 높은 백신 개발 비용: 백신 개발 및 제조에 드는 비용이 높기 때문에 백신 구입 가격 및 접근성을 제한할 수 있습니다. 이 문제는 저소득층의 반려동물 보호자가백신을 구입하기 어렵게 만들고, 평균 사육률을 떨어뜨려 시장 성장에 영향을 미칠 수 있습니다.
• 규제적 장애물: 백신 허가를 위한 복잡한 규제 요건에 대응하는 것이 과제입니다. 이러한 장애물은 새로운 백신의 도입을 지연시키고, 개발 비용을 증가시키며, 시장 역학에 영향을 미치고, 기술 혁신의 속도를 늦춥니다.
• 농촌 지역의 제한된 인식: 농촌 지역에서는 애완동물용 백신 접종의 중요성에 대한 인식이 낮아 시장 성장에 걸림돌이 될 수 있습니다. 이러한 지역에서는 백신 접종률이 낮기 때문에 종합적인 질병 관리가 어렵고, 전체 시장 보급률에 영향을 미치기 때문에 집중적인 교육 및 보급 활동의 필요성이 강조되고 있습니다.

반려동물 사육률 증가, 백신 기술 발전, 반려동물 건강에 대한 인식 개선 등 시장 성장 촉진요인은 애완동물용 백신 시장을 형성하고 성장을 가속할 것입니다. 그러나 높은 개발 비용, 규제 장벽, 지방의 낮은 인지도 등의 과제는 큰 장벽으로 작용하고 있습니다. 시장 성장 촉진요인과 과제를 극복하면서 촉진요인을 활용하는 것은 시장을 발전시키고 효과적인 애완동물용 백신에 대한 폭넓은 접근성을 확보하는 데 필수적입니다.

목차

제1장 개요

제2장 세계의 애완동물용 백신 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 애완동물용 백신 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 애완동물용 백신 시장 : 유형별
  • 개과
  • 고양이과
• 세계의 애완동물용 백신 시장 : 백신 접종별
  • 개 가족
  • 코어 백신
  • 비코어 백신
• 세계의 애완동물용 백신 시장 : 투여 경로별
  • 주사 백신
  • 비강내 백신
• 세계의 애완동물용 백신 시장 : 용도별
  • 개
  • 고양이
  • 토끼
  • 기타

제4장 지역별 시장 동향과 예측 분석(2019-2031년)

• 세계의 애완동물용 백신 시장 : 지역별
• 북미의 애완동물용 백신 시장
• 유럽의 애완동물용 백신 시장
• 아시아태평양의 애완동물용 백신 시장
• 기타 지역의 애완동물용 백신 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 애완동물용 백신 시장의 성장 기회 : 유형별
  • 세계의 애완동물용 백신 시장의 성장 기회 : 백신 접종별
  • 세계의 애완동물용 백신 시장의 성장 기회 : 투여 경로별
  • 세계의 애완동물용 백신 시장의 성장 기회 : 용도별
  • 세계의 애완동물용 백신 시장의 성장 기회 : 지역별
• 세계의 애완동물용 백신 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 애완동물용 백신 시장의 생산능력 확대
  • 세계의 애완동물용 백신 시장에서의 기업인수합병(M&A), 합병사업
  • 인증과 라이선싱

제7장 주요 기업의 개요

• Elanco
• Merck
• Ceva
• Virbac
• Zoetis
• HIPRA
• Merial

영문목차

The future of the global pet vaccine market looks promising with opportunities in the dog, cat, and rabbit applications. The global pet vaccine market is expected to reach an estimated $11.2 billion by 2031 with a CAGR of 6.1% from 2025 to 2031. The major drivers for this market are the increasing adoption of pet animals, growing awareness among pet owners about the benefits of preventive healthcare for their pets, and government regulations regarding vaccinations.

• Lucintel forecasts that, within the vaccination category, the canine family will remain the largest segment due to the rising popularity of companion animals, growing awareness of the importance of animal health, and the evolving lifestyles of pet owners.
• Within the application category, dog is expected to witness the highest growth over the forecast period.
• In terms of regions, North America will remain the largest region due to strict government regulations regarding vaccinations to protect pets from serious diseases and the rising adoption of pets in the USA.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Pet Vaccine Market

Emerging trends are reshaping the future of the pet vaccine market as it undergoes significant transformation. Developments in pet ownership patterns, technological innovations, and the increasing focus on preventive healthcare have been key drivers of these trends. The following are five major trends that are influencing the pet vaccine market.

• Personalized Pet Vaccination Plans: Personalized pet vaccination plans have become a popular trend among veterinarians who now offer customized vaccination schedules based on individual pet needs. This approach ensures that vaccines given to pets are appropriate, thereby reducing instances of over-vaccination and improving the overall health of pets. With personalized plans becoming increasingly common, pet owners looking for tailored care for their animals represent yet another example of this wider tendency toward humanizing these companions.
• Growth of Combination Vaccines: In the pet vaccine market, there is increased usage of combination vaccines, which protect against multiple diseases through a single shot. These vaccines save time and reduce anxiety levels for both pets and people because fewer vet visits are needed. Cost-effectiveness, along with rising awareness about overall wellness for pets, has led to increased demand for combination vaccines compared with other types available in many areas.
• Advances in Vaccine Technology: There is development of new vaccine formulations, including DNA and mRNA vaccines, aimed at providing better protection with reduced side effects within the pet vaccine market due to technological advancements in vaccine development. They would result in more effective vaccines that can be manufactured and delivered more efficiently to satisfy the growing global demand for high-quality pet vaccines.
• Increased Focus on Preventive Healthcare: There is a growing emphasis on preventive healthcare in the pet vaccine market, with regular vaccinations becoming increasingly important as part of routine care by pet owners. This trend is supported by veterinary professionals who advocate for proactive health management to prevent disease onset. As preventive care becomes mainstream, it will likely boost the demand for vaccinations and related health services.
• Expansion of Veterinary Services: Opening new clinics and mobile veterinary units plays a major role in expanding access to pet vaccines, especially in rural and underserved regions. The result of this trend is that vaccination rates have increased, leading to improved overall health among pets. Veterinary services will likely be pivotal in supporting the growth of the pet vaccine market as it continues to expand.

These emerging trends are reshaping the pet vaccine market by driving innovation, enhancing access to vaccines, and improving the overall standard of pet healthcare. As these trends continue to evolve, they will contribute to a more robust and dynamic market, better equipped to meet the needs of pet owners and their animals.

Recent Developments in the Pet Vaccine Market

The market for pet vaccines has undergone several developments that improve vaccine effectiveness, accessibility, and adoption. These improvements are crucial in responding to the increasing need for comprehensive pet healthcare. Below are five key developments that are significantly influencing the market.

• Introduction of Modern Vaccines: Recent developments include the introduction of modern vaccines that offer immunity against targeted diseases and have limited side effects. The new vaccines help protect against newly emerging infections among animals, raising vaccination rates and leading to better health outcomes among pets.
• Expansion of Global Vaccine Manufacturing: The expansion of global vaccine manufacturing capabilities is improving supply chain efficiency and accessibility of vaccines in different regions. This is vital since it helps meet the demand for pet vaccines in new markets by ensuring the continued supply of quality vaccines.
• Regulatory Approvals for New Vaccines: Regulatory authorities in some countries have approved specific pet vaccines related to novel diseases, reflecting the increasing emphasis on preventing diseases rather than curing them after they attack pets. This allows more specialized vaccines to be introduced, covering various needs of pets in different locations.
• Growth in Pet Insurance Coverage: The growth of pet insurance coverage, including vaccination costs, encourages more pet owners to vaccinate their pets. Higher vaccination rates and a wider range of vaccine requirements drive growth within the overall pet vaccine market.
• Collaboration Between Veterinary Professionals and Pharma Companies: Collaboration between veterinary professionals and pharmaceutical firms results in stronger vaccine development as well as improved vaccination protocols. Such alliances play an important role in promoting innovation and adapting vaccines according to the changing needs experienced by domestic animals and their owners.

These recent advancements significantly impact the pet vaccine market through improved efficiency and increased access levels, while accelerating the adoption rate. Generally, all these changes favor a more flexible pet vaccine industry that can address health issues affecting animals worldwide.

Strategic Growth Opportunities for Pet Vaccine Market

The pet vaccine market provides several strategic growth opportunities throughout various applications, driven by increasing demand for effective vaccines and a growing focus on preventive pet healthcare. Here are five major growth opportunities by application.

• Expanding Routine Vaccination Programs: Broadening the range of vaccines covered under routine vaccination programs has the potential to spur significant growth. This approach ensures comprehensive protection from multiple diseases and stimulates frequent visits to vets, thereby supporting overall pet vaccine market expansion.
• Developing Specialized Vaccines for Exotic Pets: The possibility of developing vaccines specifically for exotic pets, like reptiles and birds, represents a strategic growth opportunity. Market expansion is driven by the increasing ownership of exotic pets, while the demand for their specific health needs rises for vaccines.
• Integration with Pet Wellness Programs: Incorporating vaccines into comprehensive pet wellness programs provides a strategic growth opportunity through the promotion of preventive care. These programs include regular check-ups and vaccinations, guaranteeing consistent care for pets and reducing disease outbreaks.
• Increasing Availability of Mobile Veterinary Services: The availability of mobile veterinary services, particularly in rural areas or underserved communities, can enhance access to vaccines, creating an opportunity for growth. These services reach pet owners who cannot easily find traditional veterinary clinics, thus increasing vaccination levels.
• Growth in Pet Travel Vaccinations: The number of pet owners traveling with their animals has increased, resulting in increased demand for travel-related vaccinations. In response, developing and marketing vaccines specifically designed for traveling pets presents a strategic growth opportunity that serves the needs of this population.

The pet vaccine market is poised for significant growth acceleration due to targeted investments aimed at boosting vaccine coverage, improving access, and meeting the varied requirements of pet owners.

Pet Vaccine Market Driver and Challenges

Numerous technological, economic, and regulatory factors influence the growth of the pet vaccine market and present challenges. Vaccine efficacy is improved by technological advancements; affordability is affected by economic factors, and market dynamics are shaped by regulatory obstacles. Thus, understanding these drivers and challenges is critical to successfully navigating the market and identifying areas for growth and innovation.

The factors driving the pet vaccine market include:

• Rising Pet Ownership: The increasing number of pet owners globally drives demand for pet vaccines. As more households adopt pets, the need for vaccines to prevent common diseases grows. This trend supports market expansion and encourages the development of new vaccine products to address diverse health needs.
• Advances in Vaccine Technology: Innovations in vaccine technology, including more effective and safer formulations, are significant drivers of market growth. Advanced technologies, such as mRNA vaccines and improved delivery systems, enhance vaccine efficacy and safety, expanding market potential and addressing emerging health threats in pets.
• Growing Awareness of Pet Health: Increased awareness among pet owners about the importance of vaccinations drives market demand. As pet owners become more informed about the benefits of vaccines, they are more likely to adhere to vaccination schedules, leading to higher market adoption rates and better overall pet health.
• Government and Regulatory Support: Support from governments and regulatory bodies, including vaccination campaigns and subsidies, promotes market growth. These initiatives ensure vaccine safety and efficacy, making them accessible at reasonable prices and thereby raising vaccination levels among pets.
• Expansion of Veterinary Services: The growth of veterinary services, including new clinics and mobile units, enhances access to pet vaccines. Improved accessibility leads to higher vaccination rates, supporting market expansion to reach underserved areas and providing comprehensive pet healthcare.

Challenges in the pet vaccine market include:

• High Cost of Vaccine Development: The high cost associated with developing and producing vaccines can limit affordability and accessibility. This challenge affects market growth by making it difficult for low-income pet owners to afford them, resulting in a decrease in average ownership rates.
• Regulatory Hurdles: Navigating complex regulatory requirements for vaccine approval poses a challenge. These hurdles can delay the introduction of new vaccines and increase development costs, affecting market dynamics and slowing the pace of innovation.
• Limited Awareness in Rural Areas: Limited awareness about the importance of pet vaccinations in rural areas can hinder market growth. Low vaccination rates in these regions challenge comprehensive disease control and impact overall market adoption, highlighting the need for targeted education and outreach efforts.

Drivers such as rising pet ownership, advances in vaccine technology, and increased awareness of pet health shape the pet vaccine market and promote its growth. Nonetheless, challenges like high development costs, regulatory hurdles, and limited awareness in rural areas are substantial barriers. Addressing these challenges while leveraging growth drivers will be essential for advancing the market and ensuring broader access to effective pet vaccines.

List of Pet Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pet vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pet vaccine companies profiled in this report include-

• Elanco
• Merck
• Ceva
• Virbac
• Zoetis
• HIPRA
• Merial

Pet Vaccine by Segment

The study includes a forecast for the global pet vaccine market by type, vaccination, mode of administration, application, and region.

Pet Vaccine Market by Type [Analysis by Value from 2019 to 2031]:

• Canlane
• Feline

Pet Vaccine Market by Vaccination [Analysis by Value from 2019 to 2031]:

• Canine Family
• Core Vaccines
• Non-Core Vaccines

Pet Vaccine Market by Mode of Administration [Analysis by Value from 2019 to 2031]:

• Injectable Vaccines
• Intranasal Vaccines

Pet Vaccine Market by Application [Analysis by Value from 2019 to 2031]:

• Dogs
• Cats
• Rabbits
• Others

Pet Vaccine Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Pet Vaccine Market

The global market for pet vaccines has seen major developments in different regions due to the rise of pet ownership, awareness of pet health, and innovations made in vaccine technology. These changes help to meet the increasing need for effective vaccines that ensure pets are healthy worldwide. Here are some of the most important developments in the pet vaccine market across the United States, China, Germany, India, and Japan.

• USA: The US pet vaccine market has seen a remarkable upswing due to the emerging trend of anthropomorphism regarding pets. Recent developments include the launch of advanced vaccines that target emerging pet diseases and an increased number of veterinary practices providing custom vaccination plans. Furthermore, partnerships between biotech corporations and schools have resulted in better vaccine formulations, making pet vaccines more effective and secure.
• China: The Chinese pet vaccine market is growing rapidly as the urban population continues to adopt pets. Additionally, new regulations concerning vaccinations have been implemented by the government, propelling growth in this industry. Key highlights include the authorization of new domestically manufactured vaccines and partnerships between local firms and international companies aimed at improving quality and distribution systems, leading to an increasing demand for pet healthcare products.
• Germany: Germany's pet vaccine market thrives on research and development. Recent developments include the introduction of vaccines targeting exotic pets and an increased emphasis on preventive care measures. Moreover, significant investment has been made toward creating a robust animal health infrastructure; for example, there has been an expansion of veterinary clinics and specialist pet hospitals, allowing larger numbers to be vaccinated against various disease-causing agents and maintaining better overall health among animals.
• India: Rising middle-class households adopting pets, together with increasing awareness about pet health, have spurred growth within India's pet vaccine marketplace. Developments here include low-cost vaccine alternatives focusing on common ailments affecting domestic animals, combined with government initiatives aimed at creating awareness about available options for protecting pets against diseases through vaccination campaigns. Additionally, the entry of global veterinary pharmaceutical companies into the Indian market has increased the reliable supply of good-quality vaccines.
• Japan: The Japanese pet vaccine market is characterized by an increasing embrace of advanced vaccine techniques and personalized pet healthcare. Recent developments include the adoption of new vaccine delivery systems, such as oral vaccines that simplify administration. In addition, there has been a growing trend for pet wellness programs with comprehensive vaccination plans, indicating an appreciation of preventive healthcare among pet owners.

Features of the Global Pet Vaccine Market

Market Size Estimates: Pet vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Pet vaccine market size by various segments, such as by type, vaccination, mode of administration, application, and region in terms of ($B).

Regional Analysis: Pet vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, vaccinations, mode of administrations, applications, and regions for the pet vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pet vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the pet vaccine market by type (canlane and feline), vaccination (canine family, core vaccines, and non-core vaccines), mode of administration (injectable vaccines and intranasal vaccines), application (dogs, cats, rabbits, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Pet Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Pet Vaccine Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Pet Vaccine Market by Type
  • 3.3.1: Canlane
  • 3.3.2: Feline
• 3.4: Global Pet Vaccine Market by Vaccination
  • 3.4.1: Canine Family
  • 3.4.2: Core Vaccines
  • 3.4.3: Non-Core Vaccines
• 3.5: Global Pet Vaccine Market by Mode of Administration
  • 3.5.1: Injectable Vaccines
  • 3.5.2: Intranasal Vaccines
• 3.6: Global Pet Vaccine Market by Application
  • 3.6.1: Dogs
  • 3.6.2: Cats
  • 3.6.3: Rabbits
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Pet Vaccine Market by Region
• 4.2: North American Pet Vaccine Market
  • 4.2.1: North American Market by Vaccination: Canine Family, Core Vaccines, and Non-Core Vaccines
  • 4.2.2: North American Market by Application: Dogs, Cats, Rabbits, and Others
• 4.3: European Pet Vaccine Market
  • 4.3.1: European Market by Vaccination: Canine Family, Core Vaccines, and Non-Core Vaccines
  • 4.3.2: European Market by Application: Dogs, Cats, Rabbits, and Others
• 4.4: APAC Pet Vaccine Market
  • 4.4.1: APAC Market by Vaccination: Canine Family, Core Vaccines, and Non-Core Vaccines
  • 4.4.2: APAC Market by Application: Dogs, Cats, Rabbits, and Others
• 4.5: ROW Pet Vaccine Market
  • 4.5.1: ROW Market by Vaccination: Canine Family, Core Vaccines, and Non-Core Vaccines
  • 4.5.2: ROW Market by Application: Dogs, Cats, Rabbits, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Pet Vaccine Market by Type
  • 6.1.2: Growth Opportunities for the Global Pet Vaccine Market by Vaccination
  • 6.1.3: Growth Opportunities for the Global Pet Vaccine Market by Mode of Administration
  • 6.1.4: Growth Opportunities for the Global Pet Vaccine Market by Application
  • 6.1.5: Growth Opportunities for the Global Pet Vaccine Market by Region
• 6.2: Emerging Trends in the Global Pet Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Pet Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pet Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Elanco
• 7.2: Merck
• 7.3: Ceva
• 7.4: Virbac
• 7.5: Zoetis
• 7.6: HIPRA
• 7.7: Merial